-The Business Standard If the Cabinet clears the proposed policy, the Department of Pharmaceuticals would have to notify this before the SC?s next hearing on the matter on Nov 27 The Cabinet is likely to take up the proposed National Pharmaceutical Pricing Policy tomorrow, government sources said. The policy is aimed at capping the prices of 348 essential medicines at the weighted average of all drugs in a particular segment, with...

-Live Mint While natural disasters grab our attention, everyday events like illness drag most people into poverty  In a small town of Gujarat, I met Chandibai, a woman, about 50 years of age. Fifteen years previously, her husband, Gokalji, had owned a general-purpose shop in the town centre. The family also owned a house and some agricultural land. In 1989, Gokalji developed an illness that confined him to bed, sometimes at home...

-Live Mint Incidents at Bhopal and Indore highlight irregularities and ethical violations in some trials In 2004, doctors at the Bhopal Memorial Hospital and Research Centre (BMHRC), established exclusively for treating the victims of the 1984 gas leak, recruited unsuspecting survivors for clinical trials without their knowledge or consent; 14 participants died during the course of the trials. Together with the episode in Indore’s Maharaja Yashwantrao Hospital (that Mint reported on 10...

-The Indian Express The government’s proposal to price-control certain drugs will create more problems than it will solve From clothes to cars, prices of consumer products the world over are determined taking into account input costs, margins and competition, popularly called the cost-based pricing system. Departing from this sound, fair, tried and tested principle of commerce, the government’s new drug pricing policy, approved by the Group of Ministers headed by Sharad Pawar,...

-Live Mint The first in a two-part series examining the opaque world of clinical trials in India  A hospital in Indore has been able to get away with unethical medical trials in which 32 people have died over five years, according to the state government. This despite several investigations, a state government ban and Supreme Court strictures—a classic example of the lawless nature of the clinical trial business in India.   Lata Mehra, who...